| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $4.2M | +3216.1% |
| SG&A Expense | $4.0M | +228.3% |
| Operating Income | -$8.2M | -507.9% |
| Interest Expense | $497 | -99.7% |
| Pre-tax Income | -$8.2M | +66.3% |
| Income Tax | $10K | +70.8% |
| Net Income | -$8.2M | +66.2% |
| EPS (Basic) | -$0.59 | +91.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.4M | -23.8% |
| Current Assets | $14.9M | -18.1% |
| Total Assets | $14.9M | -18.1% |
| Current Liabilities | $1.3M | +530.2% |
| Total Liabilities | $1.7M | +765.3% |
| Stockholders' Equity | $13.2M | -26.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.4M | -366.1% |
| Capital Expenditures | $802 | +0.0% |
| Investing Cash Flow | -$802 | +0.0% |
| Financing Cash Flow | $3.2M | -82.9% |
| Free Cash Flow | -$7.4M | -365.9% |